Global $12.7 Billion Pharmacogenomics Markets to 2026 with Profiles of Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Novartis, Oxford Nanopore Technologies and Thermo Fisher Scientific
11 mai 2021 08h13 HE | Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for pharmacogenomics should...
Scipher Applies Spectra™ Platform to Discover Drugs Targeting Autoimmune Patients Refractory to Existing Therapies
04 mai 2021 08h00 HE | Scipher Medicine Corporation
- Leverages large genomic database from Scipher’s testing business.- Proven Spectra™ platform brings precision therapeutics to autoimmune diseases.- Program commercialized through pharma partnerships....
The Worldwide Patient-Derived Xenograft/PDX Model Industry is Expected to Reach $299 Million by 2026
30 avr. 2021 06h33 HE | Research and Markets
Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mouse, Rat), Tumor Type (Gastrointestinal, Gynecological, Hematological), Application (Preclinical...
2021 Global Exosome Market Size, Forecast, Trials and Trends, Featuring Profiles of 107 Competitors Including Abbexa, Ltd., Abnova, Aruna Bio and Tavec Pharma
22 avr. 2021 06h13 HE | Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2021" report has been added to ResearchAndMarkets.com's offering. ...
Global Clinical Genomics Markets Report 2021: Mergers, Acquisitions, and Partnerships Accelerate Adoption of Clinical Genomics
14 avr. 2021 04h13 HE | Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics" report has been added to ResearchAndMarkets.com's...
ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in Pet Cancer Market
13 avr. 2021 08h00 HE | ImpriMed, Inc.
PALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- ImpriMed, Inc., a leading veterinary precision medicine startup has recently closed a total of $8 million in Pre-Series A funding with $7.7...
Abcam and MEDx extend precision medicine strategic partnership
12 avr. 2021 05h00 HE | Abcam
Building on existing three-year collaborationFocusing on co-development of companion and in vitro diagnostic kits to support demand in China CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12,...
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
06 avr. 2021 07h30 HE | Progenity, Inc.
SAN DIEGO, April 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
Allarity Therapeutics Submits Premarket Approval Application to U.S. FDA for DRP® Companion Diagnostic for Dovitinib
02 avr. 2021 07h00 HE | Allarity Therapeutics A/S
- Submission precedes expected NDA filing for dovitinib in 2021 - Premarket Approval will allow U.S. marketing of DRP-Dovitinib as companion diagnostic to dovitinib Press release ...
Global Genome Sequencing Market Report 2021-2026 Featuring Prominent Players - Illumina, Thermo Fisher Scientific, Oxford Nanopore Technology, Pacific Biosciences, F. Hoffmann-La Roche, & BGI
29 mars 2021 05h23 HE | Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "Genome Sequencing Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global genome...